Related Experiment Video
Updated: May 30, 2026
08:57
Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
Published on: March 26, 2015
Promoting myelin repair and return of function in multiple sclerosis
Jingya Zhang1, Elisabeth G Kramer, Linnea Asp
1Corinne Goldsmith Dickinson Center for MS, Mount Sinai School of Medicine, New York, NY 10029, USA.
FEBS Letters
|August 26, 2011
Summary
Multiple sclerosis (MS) treatments focus on reducing inflammation but don't fully prevent disability. New therapies targeting oligodendrocyte protection and myelin repair show promise for improving long-term outcomes in MS patients.
Area of Science:
- Neuroscience
- Immunology
- Demyelinating Diseases
Background:
- Multiple sclerosis (MS) is a central nervous system (CNS) inflammatory demyelinating disease.
- Current therapies for relapsing-remitting MS are immunoregulatory, reducing lesion formation but not fully preventing disability.
- Axonal transection and neuronal loss contribute to chronic deficits in MS.
Purpose of the Study:
- To review translational research on oligodendrocyte protection and myelin repair in autoimmune demyelination models.
- To explore the potential of these strategies as novel therapies for MS.
- To clarify the relationship between demyelination and axonal transection in MS lesions.
Main Methods:
- Review of in vivo studies in genetically modified mouse models of autoimmune demyelination.
- Analysis of research targeting oligodendrocyte protection and myelin repair mechanisms.
- Evaluation of translational relevance for MS therapies.
Main Results:
- Studies in mouse models have identified mechanisms for neuropathology in MS.
- Potential avenues for oligodendrocyte protection and myelin repair have been characterized.
- No approved treatments currently target these specific mechanisms directly.
Conclusions:
- Existing MS therapies are partially effective in preventing disability.
- Novel treatments aimed at oligodendrocyte protection and myelin repair could improve long-term outcomes.
- Further research is needed to understand demyelination-axonal transection interplay and develop targeted therapies.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:15Neurogenesis and Regeneration of Nervous Tissue
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
01:25Nervous Tissue: Myelin
The myelin sheath is a multilayered lipid and protein covering that insulates the axon of a neuron, enhancing the speed of nerve impulse conduction. Axons without this sheath are referred to as unmyelinated. Two types of neuroglia, Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS) are responsible for producing myelin sheaths.
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...